- Report
- March 2024
- 187 Pages
Global
From €3237EUR$3,374USD£2,781GBP
€3596EUR$3,749USD£3,090GBP
- Report
- September 2023
- 110 Pages
Global
From €5708EUR$5,950USD£4,903GBP
- Report
- February 2024
- 175 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- November 2023
- 150 Pages
Global
From €4653EUR$4,850USD£3,997GBP
- Report
- April 2024
- 138 Pages
Global
From €3740EUR$3,899USD£3,213GBP
- Report
- May 2024
- 192 Pages
Global
From €4748EUR$4,950USD£4,079GBP
- Clinical Trials
- April 2024
- 440 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,648GBP
- Report
- February 2024
- 120 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Clinical Trials
- April 2024
- 200 Pages
Global
From €2398EUR$2,500USD£2,060GBP
- Clinical Trials
- February 2024
- 1378 Pages
Global
From €2398EUR$2,500USD£2,060GBP
- Report
- March 2024
- 200 Pages
Global
From €3981EUR$4,150USD£3,420GBP
- Report
- January 2024
- 92 Pages
North America
From €2384EUR$2,485USD£2,048GBP
€3405EUR$3,550USD£2,926GBP
- Report
- May 2024
- 186 Pages
From €3237EUR$3,374USD£2,781GBP
€3596EUR$3,749USD£3,090GBP
- Report
- April 2023
- 116 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- January 2022
- 200 Pages
Global
From €7195EUR$7,500USD£6,181GBP
- Report
- January 2022
- 200 Pages
Global
From €7195EUR$7,500USD£6,181GBP
- Report
- January 2022
- 60 Pages
Global
From €3789EUR$3,950USD£3,255GBP
- Report
- January 2022
- 60 Pages
Global
From €3789EUR$3,950USD£3,255GBP
- Report
- January 2022
- 60 Pages
Global
From €3789EUR$3,950USD£3,255GBP
The Glioblastoma Drug market is a subset of the larger Brain Cancer Drug market. It is composed of drugs used to treat glioblastoma, a type of brain cancer. These drugs are typically used in combination with surgery, radiation, and chemotherapy to treat the disease. Common drugs used to treat glioblastoma include temozolomide, bevacizumab, and lomustine. These drugs are used to reduce tumor size, slow tumor growth, and reduce symptoms.
The Glioblastoma Drug market is highly competitive, with many companies vying for market share. Some of the major players in the market include Novartis, Merck, Roche, Pfizer, and Bristol-Myers Squibb. Other companies in the market include Celgene, AstraZeneca, and Eli Lilly. Show Less Read more